ChiCTR2600119294 版本V1.0 版本创建时间2026/02/25 11:38:22 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2600119294 

最近更新日期:

Date of Last Refreshed on:

2026-02-25 11:38:16 

注册时间:

Date of Registration:

2026-02-25 00:00:00 

注册号状态:

补注册

Registration Status:

Retrospective registration

注册题目:

rTMS联合上肢多通道FES对脑卒中后早期大脑激活及脑功能网络的影响

Public title:

Effects of rTMS combined with upper limb multichannel FES on early brain activation and brain functional network after stroke

注册题目简写:

English Acronym:

研究课题的正式科学名称:

rTMS联合上肢多通道FES对脑卒中后早期大脑激活及脑功能网络的影响

Scientific title:

Effects of rTMS combined with upper limb multichannel FES on early brain activation and brain functional network after stroke

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

吕雪莹 

研究负责人:

吕雪莹 

Applicant:

lv Xueying 

Study leader:

lv Xueying 

申请注册联系人电话:

Applicant telephone:

+86 10 5698 1051

研究负责人电话:

Study leader's
telephone:

+86 10 5698 1051

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

2269074921@qq.com

研究负责人电子邮件:

Study leader's E-mail:

2269074921@qq.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

北京市石景山区工疗路北50米

研究负责人通讯地址:

北京市石景山区工疗路北50米

Applicant address:

50 meters north of Gongli Road, Shijingshan District, Beijing

Study leader's address:

50 meters north of Gongli Road, Shijingshan District, Beijing

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

首都医科大学附属北京康复医院

Applicant's institution:

Beijing Rehabilitation Hospital Affiliated to Capital Medical University

研究负责人所在单位:

首都医科大学附属北京康复医院

Affiliation of the Leader:

Beijing Rehabilitation Hospital Affiliated to Capital Medical University

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

北康科研伦理审(2024bkky-006)号

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

首都医科大学附属北京康复医院医学伦理审查小组

Name of the ethic committee:

Ethics Committee of Beijing Rehabilitation Hospital Affiliated to Capital Medical University

伦理委员会批准日期:

Date of approved by ethic committee:

2024-01-15 00:00:00

伦理委员会联系人:

王婷

Contact Name of the ethic committee:

Wang Ting

伦理委员会联系地址:

北京市石景山区工疗路北50米

Contact Address of the ethic committee:

50 meters north of Gongli Road, Shijingshan District, Beijing

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 56981486

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

首都医科大学附属北京康复医院

Primary sponsor:

Beijing Rehabilitation Hospital Affiliated to Capital Medical University

研究实施负责(组长)单位地址:

北京市石景山区工疗路北50米

Primary sponsor's address:

50 meters north of Gongli Road, Shijingshan District, Beijing

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

北京

市(区县):

Country:

China

Province:

Beijing

City:

单位(医院):

首都医科大学附属北京康复医院

具体地址:

北京市石景山区工疗路北50米

Institution
hospital:

Beijing Rehabilitation Hospital Affiliated to Capital Medical University

Address:

50 meters north of Gongli Road, Shijingshan District, Beijing

经费或物资来源:

院内课题经费

Source(s) of funding:

Research project funds within the hospital

研究疾病:

脑卒中  

Target disease:

Stroke

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

1.明确低频rTMS联合上肢多通道FES对脑卒中后早期患者的临床疗效,观察是否优于单一治疗; 2.探索联合治疗对脑卒中患者大脑激活及脑功能网络的影响,总结脑激活规律和脑功能网络的变化,为进一步制定个性化康复方案的制定提供理论依据; 3.探讨并优化组合技术的临床治疗方案并加以推广。  

Objectives of Study:

1.To clarify the clinical efficacy of low-frequency rTMS combined with upper limb multi-channel FES in early post-stroke patients and observe whether it is superior to single treatment; 2.Explore the influence of combined therapy on brain activation and brain functional networks in stroke patients, summarize the patterns of brain activation and changes in brain functional networks, and provide a theoretical basis for further formulating personalized rehabilitation plans; 3. Explore and optimize the clinical treatment plan of the combined technology and promote it.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1.符合脑卒中诊断标准; 2.头颅CT或MRI提示单侧病灶,发病3个月以内; 3.一般情况和生命体征稳定、无明显认知功能障碍,简易精神状态检查(MMSE)评分大于24分,能配合评估及治疗; 4.年龄30-70岁,患侧上肢的Brunnstrom分期为Ⅱ~Ⅳ期; 5.患方自愿参加本研究并签署知情同意书。

Inclusion criteria

1. Meets the diagnostic criteria for stroke; 2. Head CT or MRI shows a unilateral lesion, and the onset was within 3 months; 3. General condition and vital signs are stable, with no obvious cognitive impairment. The Mini-Mental State Examination (MMSE) score is greater than 24, and the patient can cooperate with the assessment and treatment; 4. Age is between 30 and 70 years old, and the Brunnstrom stage of the affected upper limb is II to IV; 5. The patient voluntarily participates in this study and signs the informed consent form.

排除标准:

1.进展性或继发性中风; 2.患侧上肢或手的肌张力改良Ashworth分级>=2级; 3.上肢有外周神经损伤或外周神经病病史的患者; 4.患有癫痫、严重心脏、肺、肝、肾和其他器官疾病的个人或家族史患者; 5.带有起搏器、耳蜗植入物和其他金属植入物的患者。

Exclusion criteria:

1. Progressive or secondary stroke; 2. Modified Ashworth scale for muscle tone of the affected upper limb or hand >= 2; 3. Patients with peripheral nerve injury or history of peripheral neuropathy in the upper limb; 4. Individuals or those with a family history of epilepsy, severe heart, lung, liver, kidney and other organ diseases; 5. Patients with pacemakers, cochlear implants and other metal implants.

研究实施时间:

Study execute time:

From 2024-01-31 00:00:00 To 2026-12-01 00:00:00  

征募观察对象时间:

Recruiting time:

From 2024-12-01 00:00:00 To 2026-12-01 00:00:00

干预措施:

Interventions:

组别:

对照组

样本量:

20

Group:

Control group

Sample size:

干预措施:

常规康复治疗

干预措施代码:

Intervention:

Conventional rehabilitation therapy

Intervention code:

组别:

FES组

样本量:

20

Group:

FES group

Sample size:

干预措施:

进行功能性电刺激治疗

干预措施代码:

Intervention:

Perform functional electrical stimulation therapy

Intervention code:

组别:

rTMS组

样本量:

20

Group:

rTMS group

Sample size:

干预措施:

进行重复经颅刺激治疗

干预措施代码:

Intervention:

Perform repetitive transcranial stimulation therapy

Intervention code:

组别:

联合组

样本量:

20

Group:

Joint group

Sample size:

干预措施:

进行功能性电刺激和重复经颅磁刺激治疗

干预措施代码:

Intervention:

Functional electrical stimulation and repetitive transcranial magnetic stimulation therapy were carried out

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

北京 

市(区县):

 

Country:

China

Province:

Beijing

City:

单位(医院):

首都医科大学附属北京康复医院 

单位级别:

三级 

Institution
hospital:

Beijing Rehabilitation Hospital Affiliated to Capital Medical University

Level of the institution:

Tertiary

测量指标:

Outcomes:

指标中文名:

功能性近红外光谱

指标类型:

主要指标

Outcome:

Functional near-infrared spectroscopy,fNIRS

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

Fugl-Meyer上肢运动功能

指标类型:

主要指标

Outcome:

Fugl-Meyer assessment of the upper extremity,FMA-UE

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

None

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age 30 years
最大 Max age 70 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

不参与受试者招募的人员完成随机数字表法

Randomization Procedure (please state who generates the random number sequence and by what method):

The personnel who were not involved in the recruitment of the subjects completed the random number table method

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

单盲,对研究参与者设盲

Blinding:

Single-blind, with the participants of the study remaining unaware of the situation

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

研究结束后,通过ResMan(www.medresman.org.cn)方式共享

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

After the end of the study, it was shared by ResMan (www.medresman.org.cn).

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

CRF;EDC

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

CRF;EDC

数据与安全监察委员会:

Data and Safety Monitoring Committee:

无/No

注册人:

Name of Registration:

 2026-02-25 11:38:16